Literature DB >> 23977546

Inflammation in malignant mesothelioma - friend or foe?

Anthony Linton1, Nico van Zandwijk, Glen Reid, Stephen Clarke, Christopher Cao, Steven Kao.   

Abstract

Year:  2012        PMID： 23977546      PMCID： PMC3741786          DOI： 10.3978/j.issn.2225-319X.2012.10.02

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  54 in total

1.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Health-related quality of life and inflammatory markers in malignant pleural mesothelioma.

Authors:  Steven C Kao; Janette Vardy; Rozelle Harvie; Mark Chatfield; Nico van Zandwijk; Stephen Clarke; Nick Pavlakis
Journal:  Support Care Cancer       Date:  2012-08-31       Impact factor: 3.603

3.  High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

Authors:  Steven C H Kao; Nick Pavlakis; Rozelle Harvie; Janette L Vardy; Michael J Boyer; Nico van Zandwijk; Stephen J Clarke
Journal:  Clin Cancer Res       Date:  2010-10-18       Impact factor: 12.531

4.  Lymphocytic infiltration of pleural mesothelioma and its significance for survival.

Authors:  R A Leigh; I Webster
Journal:  S Afr Med J       Date:  1982-06-26

5.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

6.  Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.

Authors:  Andrew Bottomley; Corneel Coens; Fabio Efficace; Rabab Gaafar; Christian Manegold; Sjaak Burgers; Mark Vincent; Catherine Legrand; Jan P van Meerbeeck
Journal:  J Clin Oncol       Date:  2007-12-20       Impact factor: 44.544

7.  Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases.

Authors:  P S Weinstein; M Skinner; J D Sipe; J J Lokich; N Zamcheck; A S Cohen
Journal:  Scand J Immunol       Date:  1984-03       Impact factor: 3.487

8.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

Authors:  M J Proctor; D C McMillan; D S Morrison; C D Fletcher; P G Horgan; S J Clarke
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

9.  Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.

Authors:  A M Al Murri; J M S Bartlett; P A Canney; J C Doughty; C Wilson; D C McMillan
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

10.  The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases.

Authors:  R Al-Shaiba; D C McMillan; W J Angerson; E Leen; C S McArdle; P Horgan
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640
View more
  12 in total

Review 1.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 2.  In vitro experimental models of mesothelioma revisited.

Authors:  Anand Singh; Nathanael Pruett; Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2017-06

3.  Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.

Authors:  M J Lathrop; E K Sage; S L Macura; E M Brooks; F Cruz; N R Bonenfant; D Sokocevic; M B MacPherson; S L Beuschel; C W Dunaway; A Shukla; S M Janes; C Steele; B T Mossman; D J Weiss
Journal:  Cancer Gene Ther       Date:  2014-12-19       Impact factor: 5.987

4.  Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity.

Authors:  David Larson; Amy Powers; Jean-Paul Ambrosi; Mika Tanji; Andrea Napolitano; Erin G Flores; Francine Baumann; Laura Pellegrini; Cormac J Jennings; Brenda J Buck; Brett T McLaurin; Doug Merkler; Cleo Robinson; Paul Morris; Meral Dogan; A Umran Dogan; Harvey I Pass; Sandra Pastorino; Michele Carbone; Haining Yang
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2016       Impact factor: 6.393

Review 5.  Switching off malignant mesothelioma: exploiting the hypoxic microenvironment.

Authors:  Noushin Nabavi; Kevin L Bennewith; Andrew Churg; Yuzhuo Wang; Colin C Collins; Luciano Mutti
Journal:  Genes Cancer       Date:  2016-11

6.  In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.

Authors:  Erasmia Rouka; Eleftherios Beltsios; Dimos Goundaroulis; Georgios D Vavougios; Evgeniy I Solenov; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Medicina (Kaunas)       Date:  2019-06-12       Impact factor: 2.430

Review 7.  Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.

Authors:  Melanie Vogl; Anna Rosenmayr; Tomas Bohanes; Axel Scheed; Milos Brndiar; Elisabeth Stubenberger; Bahil Ghanim
Journal:  Cancers (Basel)       Date:  2021-02-06       Impact factor: 6.639

Review 8.  Malignant pleural mesothelioma: an update.

Authors:  Glaucia N M Hajj; Carolina H Cavarson; Clóvis Antônio Lopes Pinto; Gabriela Venturi; João R Navarro; Vladmir C Cordeiro de Lima
Journal:  J Bras Pneumol       Date:  2021-12-13       Impact factor: 2.800

9.  Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma.

Authors:  Yun Gao; Ziyi Dai; Chenxi Yang; Ding Wang; Zhenying Guo; Weimin Mao; Zhongjian Chen
Journal:  PeerJ       Date:  2022-01-04       Impact factor: 2.984

10.  Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.

Authors:  Anna Truini; Simona Coco; Ernest Nadal; Carlo Genova; Marco Mora; Maria Giovanna Dal Bello; Irene Vanni; Angela Alama; Erika Rijavec; Federica Biello; Giulia Barletta; Domenico Franco Merlo; Alessandro Valentino; Paola Ferro; Gian Luigi Ravetti; Sara Stigliani; Antonella Vigani; Franco Fedeli; David G Beer; Silvio Roncella; Francesco Grossi
Journal:  Oncotarget       Date:  2017-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.